Basic Information
RNALocate ID: | RLID:11004047 |
RNA Symbol: | hsa-miR-629-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-629-5p |
RNA ID: | miRBase:MIMAT0004810 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 25330373 |
Tissue/Cell Line: | Colon cancer cell line (LIM1863) |
Method: | qRT-PCR|RNA sequencing |
Description: | To assess whether some miRNAs are specifically sorted into EVs we conducted a miRNA-enrichment analysis for A33-Exos, EpCAM-Exos and sMVs. MiRNAs with <2 fold changes relative to CL miRNAs were filtered out, yielding 63 miRNAs for comparison (Table 2). Data are collected from Table 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002687 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002688 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002689 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11004045 | Exosome | Plasma | 23663360 |
RLID:11004046 | Exosome | K562 cells | 24460325 |
RLID:11004048 | Microvesicle | Plasma | 23077538 |
RLID:11004049 | Microvesicle | Seminal plasma | 23539611 |
RLID:11004050 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000704 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine | |
RLID-D:11001579 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-629-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-64183 |
MNDR | hsa-miR-629-5p | Large cell neuroendocrine cancer | MNDR-E-MI-64184 |
MNDR | hsa-miR-629-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-64185 |
MNDR | hsa-miR-629-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-64186 |
MNDR | hsa-miR-629-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-64187 |
MNDR | hsa-miR-629-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-64188 |
MNDR | hsa-miR-629-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-64189 |
MNDR | hsa-miR-629-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-64190 |
MNDR | hsa-miR-629-5p | Her2-receptor positive breast cancer | MNDR-E-MI-64191 |
MNDR | hsa-miR-629-5p | Breast cancer luminal | MNDR-E-MI-64192 |
MNDR | hsa-miR-629-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-64193 |
MNDR | hsa-miR-629-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-64194 |
MNDR | hsa-miR-629-5p | Small intestine cancer | MNDR-E-MI-64195 |
MNDR | hsa-miR-629-5p | Prostate cancer | MNDR-E-MI-64196 |
MNDR | hsa-miR-629-5p | Alzheimer disease | MNDR-E-MI-64197 |
MNDR | hsa-miR-629-5p | Esophageal carcinoma | MNDR-E-MI-64198 |
MNDR | hsa-miR-629-5p | Dysautonomia familial | MNDR-E-MI-64199 |
MNDR | hsa-miR-629-5p | Leukemia | MNDR-E-MI-64200 |
MNDR | hsa-miR-629-5p | Cardiovascular disease | MNDR-E-MI-64201 |
MNDR | hsa-miR-629-5p | Lung cancer | MNDR-E-MI-64202 |
MNDR | hsa-miR-629-5p | Down syndrome | MNDR-E-MI-64203 |
MNDR | hsa-miR-629-5p | Parkinson disease | MNDR-E-MI-64204 |
MNDR | hsa-miR-629-5p | Breast cancer | MNDR-E-MI-64205 |
MNDR | hsa-miR-629-5p | Thyroid cancer | MNDR-E-MI-64206 |
MNDR | hsa-miR-629-5p | Pituitary neoplasms | MNDR-E-MI-64207 |
MNDR | hsa-miR-629-5p | Pancreatic cancer | MNDR-E-MI-64208 |
MNDR | hsa-miR-629-5p | Melanoma | MNDR-E-MI-64209 |
MNDR | hsa-miR-629-5p | Colon cancer | MNDR-E-MI-64210 |
MNDR | hsa-miR-629-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-64211 |
MNDR | hsa-miR-629-5p | Familial ovarian cancer | MNDR-E-MI-64212 |
MNDR | hsa-miR-629-5p | Acromegaly | MNDR-E-MI-64213 |
MNDR | hsa-miR-629-5p | Prostate adenocarcinoma | MNDR-E-MI-64214 |
MNDR | hsa-miR-629-5p | Carcinoma ductal breast | MNDR-E-MI-64215 |
MNDR | hsa-miR-629-5p | Glioblastoma | MNDR-E-MI-64216 |
MNDR | hsa-miR-629-5p | Glioma | MNDR-E-MI-64217 |
MNDR | hsa-miR-629-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-64218 |
MNDR | hsa-miR-629-5p | Osteosarcoma | MNDR-E-MI-64219 |
MNDR | hsa-miR-629-5p | Cervical squamous cell carcinoma | MNDR-E-MI-64220 |
MNDR | hsa-miR-629-5p | Pituitary adenoma | MNDR-E-MI-64221 |
MNDR | hsa-miR-629-5p | Lung squamous cell carcinoma | MNDR-E-MI-64222 |
MNDR | hsa-miR-629-5p | Lung adenocarcinoma | MNDR-E-MI-64223 |
MNDR | hsa-miR-629-5p | Thyroid carcinoma | MNDR-E-MI-64224 |
MNDR | hsa-miR-629-5p | Bladder urothelial carcinoma | MNDR-E-MI-64225 |
MNDR | hsa-miR-629-5p | Pancreatic adenocarcinoma | MNDR-E-MI-64226 |
MNDR | hsa-miR-629-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-64227 |
MNDR | hsa-miR-629-5p | Carcinoma renal cell | MNDR-E-MI-64228 |
MNDR | hsa-miR-629-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-64229 |
MNDR | hsa-miR-629-5p | Clear cell renal cell carcinoma | MNDR-E-MI-64230 |
MNDR | hsa-miR-629-5p | Biliary tract cancer | MNDR-E-MI-64231 |
MNDR | hsa-miR-629-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-64232 |
MNDR | hsa-miR-629-5p | Leukoencephalopathy progressive multifocal | MNDR-E-MI-64233 |
MNDR | hsa-miR-629-5p | Breast invasive carcinoma | MNDR-E-MI-64234 |
MNDR | hsa-miR-629-5p | Hepatocellular carcinoma | MNDR-E-MI-64235 |
MNDR | hsa-miR-629-5p | Familiar ovarian carcinoma | MNDR-E-MI-64236 |
MNDR | hsa-miR-629-5p | Barrett's adenocarcinoma | MNDR-E-MI-64237 |
MNDR | hsa-miR-629-5p | Hodgkin lymphoma | MNDR-E-MI-64238 |
MNDR | hsa-miR-629-5p | Ulcerative colitis | MNDR-E-MI-64239 |
MNDR | hsa-miR-629-5p | Crohn disease | MNDR-E-MI-64240 |
MNDR | hsa-miR-629-5p | Skin cutaneous melanoma | MNDR-E-MI-64241 |
MNDR | hsa-miR-629-5p | Skin melanoma | MNDR-E-MI-64242 |
MNDR | hsa-miR-629-5p | Acute myelocytic leukemia | MNDR-E-MI-64243 |
MNDR | hsa-miR-629-5p | Colorectal cancer | MNDR-E-MI-64244 |
MNDR | hsa-miR-629-5p | Nasopharynx carcinoma | MNDR-E-MI-64245 |
MNDR | hsa-miR-629-5p | Nasopharyngeal cancer | MNDR-E-MI-64246 |
MNDR | hsa-miR-629-5p | Epstein-barr virus infections | MNDR-E-MI-64247 |
MNDR | hsa-miR-629-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-64248 |
MNDR | hsa-miR-629-5p | Chronic pain | MNDR-E-MI-64249 |
MNDR | hsa-miR-629-5p | Stroke lacunar | MNDR-E-MI-64250 |
MNDR | hsa-miR-629-5p | Barrett's carcinogenesis | MNDR-E-MI-64251 |
MNDR | hsa-miR-629-5p | Breast cancer her3+ negative | MNDR-E-MI-64252 |
MNDR | hsa-miR-629-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-64253 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | HNF4A | Homo sapiens | RR00715562 |
TOP